Trellus Health (TRLS.L) Stock Price

Trellus Health Price

LSE·CLOSED
0.00
​
Market closed

Revenue has compounded at 65.8% per year over the past 3 years to 114,000.00 USD. Trellus Health's net margin stands at -6,826.3%, up from -23,608.0% several years earlier.

Trellus Health stock price

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Trellus Health business model & stock analysis

Trellus Health PLC, based in Penarth, South Glamorgan, UK, provides digital chronic condition management solutions for employers and health plans. The company focuses on inflammatory bowel diseases like Crohn's and ulcerative colitis, as well as IBS, integrating mental health support through its TrellusElevate platform. With 31 employees, it offers a personalized resilience-based self-management program grounded in clinical research. Listed on 28 May 2021, Trellus Health operates at the intersection of physical and mental health management for chronic conditions.

Frequently asked questions about Trellus Health

5 analysts currently rate the Trellus Health stock: 4 recommend buying, 1 holding and 0 selling.

Converted at the current exchange rate, the Trellus Health share trades at 0.00 EUR (0.00 USD).

The Trellus Health share (TRLS.L) is listed on 3 stock exchanges, including: London (TRLS.L), Frankfurt (85Q.F).

The revenue cannot currently be calculated for Trellus Health.

The profit cannot currently be calculated for Trellus Health.

The P/E ratio cannot be calculated for Trellus Health at the moment.

The P/S cannot be calculated for Trellus Health currently.

The Eulerpool Quality Score for Trellus Health is 5/10.

The ISIN of Trellus Health is GB00BNNFM402. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.

The WKN of Trellus Health is A3CR1T. The WKN (Wertpapierkennnummer) is a six-digit German security identification number.

The ticker of Trellus Health is TRLS.L. The ticker symbol is used to trade Trellus Health shares on the stock exchange.

Fair ValueTerminal
0.00 USD
Over-/UndervaluationTerminal
Fairly valued
Sector
Industry
Health Care Providers & Services
Number of shares
Employees
Revenue per Employee
3,677.42 USD
Revenue growth Ø5 years
EBIT growth Ø5 years
Net Income growth Ø5 years
Website
Currency
USD
Initial public offering
May 28, 2021
ISIN
GB00BNNFM402
Cusip
G9026S102
Market capitalization
2,887.03 USDMicro Cap
52-Week Range
PEG
—
P/E ratio
P/Ee
—
P/S
P/Se
—
EV/EBIT
—
P/B Ratio
0.00
ROE (Return on Equity)
ROA (Return on Assets)
ROCE (Return on Capital Employed)
ROIC (Return on Invested Capital)
-66.13 %
Last updated Oct 31, 2026, 12:42 AM

Trellus Health Peer Group

Trellus Health Ticker

FRANKFURT · 85Q.FLONDON · TRLS.LLONDON STOCK EXCHANGE · TRLS.L

Trellus Health FIGI

TRLS:LN · BBG0113B34B4TRLSGBX:XH · BBG0118803S3TRLSGBX:XF · BBG0118803V9TRLSGBX:XE · BBG0118803X7TRLSGBX:XL · BBG0118803Z5TRLSGBX:XG · BBG011880401TRLSGBX:XO · BBG011880410TRLSGBX:XA · BBG011880456TRLSGBX:XT · BBG011880474TRLSGBX:XW · BBG011880483TRLSGBX:XU · BBG011880492TRLSGBX:XV · BBG0118804C8

All fundamentals and in-depth analysis of Trellus Health

Our stock analysis for Trellus Health stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Trellus Health. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.